TITLE

Prevalence of HIV and hepatitis C virus infections among inmates of Quebec provincial prisons

AUTHOR(S)
Poulin, Céline; Alary, Michel; Lambert, Gilles; Godin, Gaston; Landry, Suzanne; Gagnon, Hélène; Demers, Éric; Morarescu, Elena; Rochefort, Jean; Claessens, Christiane
PUB. DATE
July 2007
SOURCE
CMAJ: Canadian Medical Association Journal;7/31/2007, Vol. 177 Issue 3, p252
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: To determine the prevalence of HIV and hepatitis C virus (HCV) infections and examine risk factors for these infections among inmates in Quebec provincial prisons. Methods: Anonymous cross-sectional data were collected from January to June 2003 for men (n = 1357) and women (n = 250) who agreed to participate in the study and who completed a self-administrated questionnaire and provided saliva samples. Results: The prevalence of HIV infection was 2.3% among the male participants and 8.8% among the female participants. The corresponding prevalence of HCV infection was 16.6% and 29.2%, respectively. The most important risk factor was injection drug use. The prevalence of HIV infection was 7.2% among the male injection drug users and 0.5% among the male non-users. Among the women, the rate was 20.6% among the injection drug users, whereas none of the non-users was HIV positive. The prevalence of HCV infection was 53.3% among the male injection drug users and 2.6% among the male non-users; the corresponding values among the women were 63.6% and 3.5%. Interpretation: HIV and HCV infections constitute an important public health problem in prison, where the prevalence is affected mainly by a high percentage of injection drug use among inmates.
ACCESSION #
25809244

 

Related Articles

  • Prevalence of HIV and hepatitis C virus infections among inmates of Ontario remand facilities. Calzavara, Liviana; Ramuscak, Nancy; Burchell, Ann N.; Swantee, Carol; Myers, Ted; Ford, Peter; Fearon, Margaret; Raymond, Sue // CMAJ: Canadian Medical Association Journal;7/31/2007, Vol. 177 Issue 3, p257 

    Background: Each year more than 56 000 adult and young offenders are admitted to Ontario's remand facilities (jails, detention centres and youth centres). The prevalence of HIV infection in Ontario remand facilities was last measured over a decade ago, and no research on the prevalence of...

  • Within-host and between-host evolutionary rates across the HIV-1 genome. Alizon, Samuel; Fraser, Christophe // Retrovirology;2013, Vol. 10 Issue 1, p1 

    Background: HIV evolves rapidly at the epidemiological level but also at the within-host level. The virus' within-host evolutionary rates have been argued to be much higher than its between-host evolutionary rates. However, this conclusion relies on analyses of a short portion of the virus...

  • Treatment of acute hepatitis C in HIV infection. Vogel, Martin; Rockstroh, Jürgen K. // Journal of Antimicrobial Chemotherapy (JAC);Jan2010, Vol. 65 Issue 1, p4 

    Within Europe and recently in the USA and Australia an ongoing epidemic of acute hepatitis C virus (HCV) infections among HIV-positive individuals, mainly men who have sex with men, has been observed. Other concomitant sexually transmitted diseases and sexual practices with a high risk of...

  • Treatment of hepatitis C in HIV-infected patients: significant progress but not the final step. Manns, Michael P.; Wedemeyer, Heiner // JAMA: Journal of the American Medical Association;12/15/2004, Vol. 292 Issue 23, p2909 

    Reports that hepatitis C virus (HCV) has become a major cause of morbidity and death in human immunodeficiency virus (HIV) infection. Statistics; Use of antiretroviral therapy to treat HCV; Reasons why the interactions between HCV and HIV are difficult to investigate; Treatment options; Risks...

  • Prevalence of HIV and hepatitis C virus infections among inmates of Quebec provincial prisons. Poulin, Céline; Alary, Michel; Lambert, Gilles; Godin, Gaston; Landry, Suzanne; Gagnon, Hélène; Demers, Éric; Morarescu, Elena; Rochefort, Jean; Claessens, Christiane // CMAJ: Canadian Medical Association Journal Supplement;7/31/2007, Vol. 177 Issue 3, p252 

    Background: To determine the prevalence of HIV and hepatitis C virus (HCV) infections and examine risk factors for these infections among inmates in Quebec provincial prisons. Methods: Anonymous cross-sectional data were collected from January to June 2003 for men (n= 1357) and women (n= 250)...

  • Deadly disregard: government refusal to implement evidence-based measures to prevent HIV and hepatitis C virus infections in prisons. Elliott, Richard // CMAJ: Canadian Medical Association Journal Supplement;7/31/2007, Vol. 177 Issue 3, p262 

    The author comments on two studies published within the issue on the prevalence of HIV and hepatitis C virus infections among inmates of Ontario remand facilities and among inmates of Quebec provincial prisons. He references findings from other related studies. He ponders on the actions taken by...

  • Molecular Mechanism of Hepatic Injury in Coinfection with Hepatitis C Virus and HIV. Balasubramanian, Anuradha; Koziel, Margaret; Groopman, Jerome E.; Ganju, Ramesli K. // Clinical Infectious Diseases;7/1/2005 Supplement, Vol. 41, pS32 

    We have previously shown that hepatocytes exposed to hepatitis C virus (HCV) and human immunodeficiency virus (HIV) envelope proteins undergo apoptosis. In this article, we further elucidate the signaling mechanisms that mediate this effect. We found that, in human hepatocellular carcinoma...

  • Investigating Neurocognitive Features of Hepatitis C Virus Infection in Drug Users: Potential Challenges and Lessons Learned from the HIV Literature. Gonzalez, Raul; Jacobus, Joanna; Martin, Eileen M. // Clinical Infectious Diseases;7/1/2005 Supplement, Vol. 41, pS45 

    Studies of neuro cognition in drug users with hepatitis C virus (HCV) infection are urgently needed but face many challenges. We review similarities between human immunodeficiency virus (H IV) and HCV infection in their neurocognitive features, discuss challenges associated with research among...

  • Outcomes among Patients with End-Stage Liver Disease Who Are Coinfected with HIV and Hepatitis C Virus. Neff, Guy W.; Shire, Norah J.; Rudich, Steven M. // Clinical Infectious Diseases;7/1/2005 Supplement, Vol. 41, pS50 

    In at-risk populations, shared routes of transmission lead to high rates of concordance between infection with human immunodeficiency virus (HIV) type 1 and hepatitis C virus (HCV). In the era of highly active anti-retroviral therapy (HAART), end-stage liver disease (ESLD) has emerged as a...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics